Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.327
Delayed Data
As of 12:52pm ET
 +0.0012 / +0.38%
Today’s Change
0.14
Today|||52-Week Range
0.43
+39.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-65.8M-135.6M-114.7M-80.2M
 
 
 
 
 
Depreciation11.0K11.0K56.0K189.0K
 
 
 
 
 
Total Other Cash Flow13.5M57.0M29.7M5.0M
 
 
 
 
 
Funds From Operations-52.3M-78.7M-85.0M-75.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-14.5M-24.1M-6.3M-19.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-37.8M-54.6M-78.6M-55.7M
 
 
 
 
 
 
InvestingCapital Expenditures---33.7M-6.8M-4.9M
 
 
 
 
Fixed Asset Disposal1.0K------
 
 
Other Investing - Uses0.00-2.6M0.000.00
 
 
Net Cash Flow Investing1.0K-36.4M-6.8M-4.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings-2.3M24.5M6.4M5.7M
 
 
 
 
 
Long Term Debt Reduction-2.3M-25.0K-1.5M0.00
 
 
 
 
Net Proceeds Stock Sale53.6M63.3M89.1M32.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00--287.0K0.00
 
 
Other Uses - Financing0.001.9M--0.00
 
 
Net Cash Flow - Financing49.0M85.8M94.2M38.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00-456.0K6.1M
 
 
 
 
Net Change In Cash11.2M-5.1M8.9M-22.3M